atracurium - CISMeF

Preferred Label : atracurium;

MeSH definition : A non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.;

CISMeF synonym : wellcome brand of atracurium besilate; glaxo wellcome brand of atracurium besilate; pisa brand of atracurium besilate;

MeSH hyponym : 33 A 74; tracrium; relatrac; atracurium besylate; BW-33A; A 74, 33; BW 33A; BW33A; Atracurium Besilate; Besilate, Atracurium; Atracurium Dibesylate;

MeSH CAS label : isoquinolinium, 2,2'-(1,5-pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl))-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-;

MeSH Related Number : atracurium besylate; 64228-81-5 (besylate); 40AX66P76P; 64228-79-1;

Registry Number MeSH : 64228-79-1;

Related CAS MeSH : 64228-81-5 (Atracurium besylate);

Wikipedia link : https://en.wikipedia.org/wiki/Atracurium besilate;

Is substance : O;

UNII : 2GQ1IRY63P;

Details

Origin ID

D001279;

UMLS CUI

C0004234;

ATC code(s)
- atracurium [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Pharmacological action(s)
- neuromuscular agents [MeSH Descriptor]
- neuromuscular nondepolarizing agents [MeSH Descriptor]
- nicotinic antagonists [MeSH Descriptor]
Record concept(s)
- 33 A 74 [MeSH concept]
- BW-33A [MeSH concept]
- atracurium [MeSH concept]
- atracurium besylate [MeSH concept]
- relatrac [MeSH concept]
- tracrium [MeSH concept]
Related MeSH Supplementary Concept(s)
- cisatracurium [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Atracurium [LOINC component]
- Atracurium [NCIt concept]
- Atracurium (substance) [SNOMED CT concept]
- Atracurium besilate [ICD-11 Extension code]
- Product containing atracurium (medicinal product) [SNOMED CT concept]
- atracurium [ATC Code]
- atracurium [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients